Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma.
about
Positron emission tomography imaging of prostate cancerPositron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response MonitoringMetabolic Imaging in Prostate Cancer: Where We AreNon-invasive molecular imaging of prostate cancer lymph node metastasis.Synthesis and evaluation of [64Cu]PSMA-617 targeted for prostate-specific membrane antigen in prostate cancerPotential Biomarker of L-type Amino Acid Transporter 1 in Breast Cancer Progression.GCPII imaging and cancer.Challenges in clinical prostate cancer: role of imaging.Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial.Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PETMolecular imaging of the kidneysAnti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease.Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysisMetabolic positron emission tomography imaging in cancer detection and therapy response.Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CTPilot evaluation of anti-1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinomaExperimental models to study lymphatic and blood vascular metastasis.The next generation of positron emission tomography radiopharmaceuticals in oncology.Synthesis, Radiolabeling, and Biological Evaluation of (R)- and (S)-2-Amino-5-[(18)F]fluoro-2-methylpentanoic Acid ((R)-, (S)-[(18)F]FAMPe) as Potential Positron Emission Tomography Tracers for Brain Tumors.New agents and techniques for imaging prostate cancer.PET/CT Imaging and Radioimmunotherapy of Prostate CancerImaging prostate cancer: an update on positron emission tomography and magnetic resonance imagingMolecular imaging of prostate cancer: PET radiotracers.Boramino acid as a marker for amino acid transporters.PET/CT in prostate cancer: non-choline radiopharmaceuticals.Emission guided radiation therapy for lung and prostate cancers: a feasibility study on a digital patient.Imaging techniques for prostate cancer: implications for focal therapyImaging localized prostate cancer: current approaches and new developments.Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptakeReproducibility and reliability of anti-3-[¹⁸F]FACBC uptake measurements in background structures and malignant lesions on follow-up PET-CT in prostate carcinoma: an exploratory analysisBiodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer.Molecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer.11C-acetate PET/CT before radical prostatectomy: nodal staging and treatment failure prediction.Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.New horizons in prostate cancer imaging.Translational Molecular Imaging of Prostate Cancer.Humanized radioiodinated minibody for imaging of prostate stem cell antigen-expressing tumorsNovel tracers and their development for the imaging of metastatic prostate cancer.Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET.Molecular imaging of urogenital diseases.
P2860
Q24596241-EA20A3BD-7B1F-45D9-8341-006C28B2E654Q26765882-50A77A72-6029-4130-BC71-F4EA5FF26E6AQ28074429-88DD6332-709C-4D22-84FE-CBF5618721B5Q33557567-39A19227-07DD-4AF7-9A8B-513B9BD09CAEQ33700114-B4D4A40B-CFF1-4C55-97E1-7E805C3540A2Q33704472-6711087A-846D-46BE-86EE-1EEB5F48D22EQ33827632-74B4C649-E52F-4E47-815D-57E5DE5BF2A5Q33945133-93DE8287-FD88-49E5-865D-9FEF106A3907Q34139498-66B7CF99-A6D2-4F91-8FC5-51FD2F30B88AQ34235986-E36B76CA-5D34-4B51-B577-AB4CE401EE0AQ34408777-259F98E8-7802-49B4-85B5-09D966EC41BEQ34451031-3CD02300-3F2A-4965-89B9-15CA192A3F39Q34681143-406000EA-91BA-4D82-94E2-052FCA3F11A4Q34786518-F2969A14-1912-4CFC-8146-6884B5ADF441Q34995973-FAE0D60E-924C-4965-9E4E-DFA746307258Q35116088-D37C88BE-9D22-4EFE-A075-9D6DA7B25BD2Q35446777-ACF39575-3589-4E49-9950-5E74C5BAD4E9Q35525690-EECF569F-42C6-4DF4-812F-CD1115280C11Q35764792-30B58899-C5F7-438B-AF2E-76738AEAA21DQ35911784-F0D826C6-8FE9-411C-B9E3-4C2F21D0A1E0Q36085426-833607A0-0593-4DBD-BCBE-578D1966953AQ36125199-28F7D6DA-DD30-4E6D-A86D-32239F481B3DQ36129937-DD113DEA-3ED2-4291-9D5B-FC719AC276ABQ36276935-3E72E84C-9DF8-43BA-BBB2-7BD524AC008EQ36308766-2FC7F77E-CB6E-4C17-B33A-49F4A52BD732Q36419938-89EDF93B-A261-4191-991F-9CE180DB9E7EQ36460818-73E1AB6F-3689-4527-8FA2-A673684634AAQ36469177-7A70C9D6-804F-4013-B3AB-6527BA2855B0Q36533826-00EE0FD0-1C31-403B-ADB5-19D4B944D35DQ36839766-C5E28E64-89FD-4F2C-9A7C-5CA1B7D99C7BQ37091554-0D3F0979-DC46-4715-B237-A8966F6C34A9Q37092020-A39E23C7-AD2A-4A2C-8F10-86DFF65CD448Q37209479-ADC55038-32B4-46FB-96E2-985097ADF134Q37236103-69E490B5-F78E-430E-BA19-6FFD9D60DD48Q37242030-ADFF4A24-3FCD-491D-95CE-4691C75758E3Q37244969-D5B6F952-1BDF-45D1-86F9-92B0529F3C69Q37289040-E517F56E-AF9B-4CFA-8192-1819C6ABF4C6Q37321810-012735E9-94EF-466C-9410-0B25A8484D2CQ37325974-FA0515B2-A1C9-4F9C-80E9-D18A5C339785Q37550399-FFF6ADCA-5698-4F4E-85C2-C192FF2907E9
P2860
Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Initial experience with the ra ...... PET/CT in prostate carcinoma.
@en
type
label
Initial experience with the ra ...... PET/CT in prostate carcinoma.
@en
prefLabel
Initial experience with the ra ...... PET/CT in prostate carcinoma.
@en
P2093
P1476
Initial experience with the ra ...... PET/CT in prostate carcinoma.
@en
P2093
David M Schuster
F DuBois Bowman
John R Votaw
Jonathon A Nye
Mark M Goodman
Muta M Issa
Peter T Nieh
Viraj Master
Weiping Yu
P407
P577
2007-01-01T00:00:00Z